The PennZone

  • Home
  • Health
  • Business
  • Non-profit
  • Technology
  • Services
  • Construction
  • Sports
  • Books

Molham Abdulsamad, MD, Joins the Actuated Medical – Medical Advisory Board
The PennZone/10294707

Trending...
  • UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
  • Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board
  • Phinge Founder & CEO Robert DeMaio Ranked #1 Globally on Crunchbase, Continues to Convert Previous Debt Owed to Him by Phinge into Convertible Notes
Actuated Medical Inc.
BELLEFONTE, Pa. - PennZone -- Actuated Medical is excited to announce the appointment of Dr. Abdulsamad to their Medical Advisory Board. A highly respected expert in gastroenterology and advanced therapeutic endoscopy, Dr. Abdulsamad is a board-certified and fellowship-trained gastroenterologist with a clinical focus on third space endoscopy, complex resections and advanced therapeutic endoscopy including endoscopic submucosal dissection (ESD), peroral endoscopic myotomy (POEM), endoscopic full thickness resection (EFTR), submucosal tunneling endoscopic resection (STER), endoscopic ultrasound (EUS), and endoscopic retrograde cholangiopancreatography (ERCP). He brings extensive expertise and a passion for patient care that will greatly contribute to Actuated Medical's ongoing mission to improve healthcare solutions.

"We are delighted to welcome Dr. Abdulsamad to our Medical Advisory Board. His specialized knowledge in gastroenterology, along with his dedication to improving patient outcomes, will be invaluable as we continue to develop groundbreaking medical technologies. We believe his insights will play a key role in guiding our future endeavors."

— Maureen L. Mulvihill, Ph.D., Actuated Medical President & CEO

"I am thrilled and honored to be working with such great talent to help engineer innovative devices that could potentially change the outcome of many patients. I am excited to collaborate with the Actuated team and contribute my expertise in Gastroenterology and endoscopic tissue resections which will serve our patients and help advance the company's mission." — Molham Abdulsamad, M.D., F.A.C.P.

More on The PennZone
  • Walmart $WMT and COSTCO.COM $COST Distribution as SonicShieldX™ Platform Sets the Stage for Accelerated Growth in 2026: AXIL Brands (N Y S E: AXIL)
  • AI-Driven Drug Development with Publication of New Bioinformatics Whitepaper for BullFrog AI: $BFRG Strengthens Its Position in AI Drug Development
  • IQSTEL Enters 2026 from a Position of Strength Following Transformational Year Marked by N A S D A Q Uplisting, Record Revenue and First-Ever
  • Are You Hiring The Right Heater Repair Company in Philly?
  • Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board

Dr. Abdulsamad earned his medical degree from Jordan University of Science and Technology. He further honed his expertise with a residency and fellowship at BronxCare Health System, an affiliate with Mount Sinai. He is board-certified by the American Board of Internal Medicine in both gastroenterology and internal medicine. Dr. Abdulsamad's 18 years of comprehensive experience, especially in gastroenterology, and commitment to advancing medical practices will help shape Actuated Medical's strategic initiatives. His deep understanding of the latest advancements in gastroenterology will support the company's efforts to create cutting-edge medical solutions that improve patient care.

About Actuated Medical, Inc.

Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. With an unwavering focus on innovation, safety, and superior quality, the Actuated team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 42 issued U.S. and international patents, 8 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020), Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania, certified with ISO 13485 and as a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation. actuatedmedical.com

More on The PennZone
  • Appliance EMT Expands Professional Appliance Repair Services to Hartford, Connecticut
  • Java Holdings LLC Acquires +Peptide, Expanding Portfolio Across Coffee, Science, and Functional Nutrition
  • OneSolution® Expands to Orlando with New Altamonte Springs Implant Center
  • Indian Peaks Veterinary Hospital Launches Updated Dental Services Page for Boulder Pet Owners
  • Dugan Air Donates $10,000 to Indian Creek Schools

###

For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.

Additional information can be found by visiting:

ActuatedMedical.com

GripTract.com

ActuatedNeuroscience.com

TubeClear.com

Contact
Actuated Medical, Inc.
***@actuatedmedical.com


Source: Actuated Medical, Inc.

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on The PennZone
  • Together We Dance Foundation Announces Transformational Support from NAC Have a Heart Foundation
  • Harry Hayman Celebrates Years of WHYY Coverage, Partnership & Shared Commitment to Philadelphia
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Stockwell Elastomerics expands micro molding capabilities
  • Price Improvement on Luxurious Lāna'i Townhome with Stunning Ocean Views
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
  • CredHub and Real Property Management Join Forces to Empower Franchise Owners with Rental Payment Credit Reporting Solutions
  • Leimert Park Announces Weeklong Kwanzaa Festival & Kwanzaa Parade Celebrating Black History, Culture, and Community
  • Schmuck Lumber Ace Hardware Opens New Greenhouse Addition
  • Renowned Alternative Medicine Specialist Dr. Sebi and His African Bio Mineral Balance Therapy Are the Focus of New Book
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • Why Millions Are Losing Sexual Sensation, And Why It's Not Age, Hormones, or Desire
  • Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
  • Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
  • UK Financial Ltd Launches U.S. Operations Following Delaware Approval
  • Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase
  • Top Tips for Hiring HVAC Contractors in Philadelphia
  • Harry Hayman of Feed Philly Coalition Proudly Supports Sharing Excess' Holiday Food Rescue — Bri
  • Virtual Pizza Academy Announces the Return of Two Acclaimed Live Classes in 2026:
  • Teresa James & The Rhythm Tramps announce their new album and debut on MoMojo Records, 'Bad at Being Good'

Popular on PennZone

  • UK Financial Ltd Board of Directors Establishes Official News Distribution Framework and Issues Governance Decision on Official Telegram Channels - 176
  • Phinge CEO Ranked #1 Globally by Crunchbase for the Last Week, Will Be in Las Vegas Jan. 4-9, the Week of CES to Discuss Netverse & IPO Coming in 2026 - 159
  • Inside the Fight for Affordable Housing: Avery Headley Joins Terran Lamp for a Candid Bronx Leadership Conversation
  • T-TECH Partners with Japan USA Precision Tools for 2026 US Market Development of the New T-TECH 5-Axis QUICK MILL™
  • New YouTube Channel Pair Launches to Bring Entertainment Nostalgia Back to Life
  • Twin Flame Visions Disrupts the Industry With Record Ad Performance and Rapid User Growth
  • SIMM Capital Fund Surpasses $25M Raised and $100M+ in Real Estate Assets
  • $80M+ Backlog as Florida Statewide Contract, Federal Wins, and Strategic Alliance Fuel Next Phase of AI-Driven Cybersecurity Growth: Cycurion $CYCU
  • Controversial Vegan Turns Rapper Launches First Song, "Psychopathic Tendencies."
  • Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates

Similar on PennZone

  • Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board
  • 2025: A Turning Point for Human Rights. CCHR Demands End to Coercive Psychiatry
  • UK Financial Ltd Executes Compliance Tasks Ahead Of First-Ever ERC-3643 Exchange-Traded Token, SMCAT & Sets Date For Online Investor Governance Vote
  • Trump's Executive Order Rescheduling Cannabis: Accelerating M&A in a Multibillion-Dollar Industry
  • Documentary "Prescription for Violence: Psychiatry's Deadly Side Effects" Premieres, Exposes Link Between Psychiatric Drugs and Acts of Mass Violence
  • Nextvisit Co-Founder Ryan Yannelli Identifies Six Critical Factors for Behavioral Health Providers Evaluating AI Scribes in 2026
  • Psychiatric Drug Damage Ignored for Decades; CCHR Demands Federal Action
  • UK Financial Ltd Launches U.S. Operations Following Delaware Approval
  • Women's Everyday Safety Is Changing - The Blue Luna Shows How
  • SNS Research Group has published its flagship report, "Dermatological Drugs Market: 2025–2035"
Copyright © The PennZone | Theme: OMag by LilyTurf Themes
  • Contribute
  • Privacy Policy
  • Terms of Service
  • Contact Us